Skip to main content
. 2016 Oct 27;10:157–167. doi: 10.4137/BCBCR.S40075

Figure 5.

Figure 5

Myd88 does not directly affect tumor cell viability or cell cycle progression.

Notes: (A) Following 72 hours of in vitro growth, consMydlow cells and indMydlow cells treated with 2 µg/mL tetracycline or 4T1 cells treated with 100 µM of a Myd88-specific inhibitory peptide (MP) were assessed for viability by trypan blue exclusion. (B) Following 72 hours of in vitro growth, the same cell lines were assessed for cell cycle progression. Comparisons were made to each of the appropriate controls (cntrl). All data represent the average and standard error of at least three separate experiments.